PATH vs PRCT
Uipath Inc (PATH) versus Procept Biorobotics Corp (PRCT) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Procept Biorobotics Corp (PRCT) is a medical devices company listed on US.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported PRCT revenue for 2024-12-31 was $224.5M. Net income was -$91.4M. Revenue was up 64.8% from 2023-12-31 to 2024-12-31. PRCT currently screens at market cap $1.52B.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. PRCT currently screens at market cap $1.52B.
Not investment advice. Open the PATH and PRCT stock pages for the full models.
Not investment advice.